Accessing Mobility Using Wearable Sensors

Launched by BAYLOR COLLEGE OF MEDICINE · Mar 10, 2020

Keywords

ClinConnect Summary

This clinical trial, called "Accessing Mobility Using Wearable Sensors," is looking at how wearable devices can help track changes in movement and thinking abilities in patients with chronic illnesses like Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF). The study has two main goals: first, to understand how these diseases might affect a person's ability to move and think, and second, to see if an exercise program delivered through telemedicine (online rehabilitation) can improve these abilities.

To be eligible for this trial, participants need to be at least 18 years old and have a diagnosis of either COPD or CHF. The study will focus on veterans who can walk at least 10 meters, as those who have more severe mobility issues might not be able to participate. If enrolled, participants will wear a device that tracks their movements and may take part in online exercise sessions. It’s important to know that while participants will need to sign consent forms to join the study, there are certain health conditions that might exclude someone from participating, such as severe cognitive or visual impairments. Overall, this trial aims to help improve the quality of life for individuals with these chronic conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any individual 18 years old or 65+ older is eligible to participate.
• • Must be diagnosed with a chronic illness such as COPD or CHF.
• • Should be refereed to one of the tele-rehabilitation program offered at VA-Houston.
• • The investigators will be enrolling veteran subjects
• Exclusion Criteria:
• • Non-ambulatory (unable to walk with or without assistance a distance of at least 10 meter).
• • Unlikely to fully comply with the protocol (e.g., long-distance travel if multiple follow-up visits are required)
• • Unwilling to provide informed consent.
• • Severe visual and hearing problems who may not be able to interact with tele-rehabilitation.
• • Unstable medical region (those who may change medication over next 12 weeks).
• • Severe cognitive impairment and psychiatric problems who may not be able to follow tele-rehabilitation instructions based on judgement of clinical investigators.
• • Participating in another active intervention that may affect cognitive-motor performance, and those who do not have capacity to consent.
• • The investigators will not exclude patients with internal devices such as a deep brain stimulator or electronic devices for pain management, but the investigators will not be placing Bioharness device in people with such conditions.